CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of enzalutamide in the treatment of subjects with metastatic prostate cancer. The purpose of this study is to assess if ADT + docet...
Phase 2
Charlotte, North Carolina, United States
Prostate cancer has the second highest incidence rate and is the fifth leading cause of cancer-related deaths among men wo ...
Phase 1
Huntersville, North Carolina, United States of America and 25 other locations
the safety and preliminary antitumor activity of ORIC-944 as a single agent and in combinations with ARPIs in patients with metastatic prostate...
Phase 1
Charlotte, North Carolina, United States and 26 other locations
study is focused on participants with previously treated metastatic prostate cancer.The main purpose of the study is to look at the...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 12 other locations
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...
Phase 3
Concord, North Carolina, United States and 378 other locations
The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...
Phase 2
Charlotte, North Carolina, United States and 240 other locations
second-line androgen receptor (AR) directed therapy with enzalutamide or docetaxel (chemotherapy) for treating metastatic castration-resistant prostate...
Phase 3
Salisbury, North Carolina, United States of America and 230 other locations
and tolerability of xaluritamig monotherapy in adult participants with high-risk biochemical recurrent (BCR) nonmetastatic castration-sensitive prostate...
Phase 1
Charlotte, North Carolina, United States and 10 other locations
The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetax...
Phase 3
Monroe, North Carolina, United States and 72 other locations
The main objective of the study is to compare overall survival in participants receiving xaluritamig versus investigator's choice (cabazitaxel or sec...
Phase 3
Charlotte, North Carolina, United States and 164 other locations
Clinical trials
Research sites
Resources
Legal